 | MacroGenics, Inc. | |||
| NMS : MGNX || Location: United States | ||||
$16.23+0.82 (+5.32%) |
0.65 M | 15.62 - 16.58 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 6.447 M |
| March 15, 2024 | 5.603 M |
| Feb. 29, 2024 | 5.019 M |
| Feb. 15, 2024 | 6.380 M |
| Jan. 31, 2024 | 8.338 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.16 | -0.75 | -378.32% |
| 09/30/2023 | -0.10 | 0.28 | 387.18% |
| 06/30/2023 | -0.53 | -0.69 | -29.80% |
| 03/31/2023 | 0.46 | -0.61 | -232.26% |
| 12/31/2022 | 0.10 | 0.21 | 101.73% |
MGNX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 62.560M | Shares Float | 52.169M |
| Short Float | 6.447M | Market Cap | 964.05M |
| Institution ownership | 99.32% | Insider ownership | 2.613% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.15 | Forward EPS | -2.01 |